Hand-Holding, Stress Ball Don't Cut Anxiety in Skin CA Removal

Share this content:
Hand-Holding, Stress Ball Don't Cut Anxiety in Skin CA Removal
Hand-Holding, Stress Ball Don't Cut Anxiety in Skin CA Removal

THURSDAY, July 19, 2018 (HealthDay News) -- Hand-holding and squeezing a stress ball do not provide anxiety reduction among patients during excisional removal of non-melanoma skin cancer, according to a study published online July 18 in JAMA Dermatology.

Arianna F. Yanes, from Northwestern University in Chicago, and colleagues conducted a randomized trial involving 135 adults who required excisional removal of non-melanoma skin cancer of the head or neck. Participants were randomized to hand-holding, stress ball, or control (treatment as usual) in a 1:1:1 ratio.

The researchers found that in all groups, anxiety decreased over time, but no significant differences were found between the groups in the three anxiety measures (visual analogue scale [VAS] anxiety score before: control group, 3.11; hand-holding group, 3.04; stress ball group, 3.09 [P > 0.99]; VAS anxiety score during: 1.89, 2.31, and 2.47, respectively [P = 0.55]; and six-item State Trait Anxiety Inventory score: 8.91, 8.93, and 8.76, respectively [P = 0.96]). Postoperative pain scores did not differ significantly between the groups (0.78, 0.64, and 0.67, respectively [P = 0.85]). More than 99 percent of participants (99.2 percent) were very satisfied. Preoperative anxiety VAS scores were higher for participants who had done research versus those who did not do research (3.84 versus 2.62; P = 0.04).

"Hand-holding and squeezing a stress ball do not appear to provide incremental anxiety reduction in patients during excisional skin cancer surgery," the authors write.

One author disclosed financial ties to the biotechnology industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »